SANE Australia welcomes decision to provide greater access to mental illness treatments

SANE Australia congratulates the federal government for today’s decision to list additional medicines on the Pharmaceutical Benefits Scheme (PBS).

The listings include two antipsychotic medications – Invega Sustenna used in the treatment of schizophrenia, and Saphris, which is used in the treatment of bipolar 1 disorder and schizophrenia.

‘The listing of these medications on the PBS means that many more Australians living with distressing and often debilitating illnesses will be able to more easily access a wider range of treatments,’ says the Executive Director of SANE Australia, Barbara Hocking.

SANE Australia believes it is critical to include new medications for mental illnesses on the PBS. Medication is often the cornerstone of treatment and enables people to benefit from other essential non-drug community and education programs.

Today’s announcement is welcome. We congratulate the Consumers Health Forum for their leadership in bringing about this agreement.

‘We look forward to working with them to develop a strategy that can strengthen the PBS while keeping costs at a reasonable level and improving health,‘ Ms Hocking adds.


SANE Australia offers a wide range of resources to assist people diagnosed with mental illness and their families. Call the SANE Helpline on 1800 18 SANE (7263) or visit sane.org for more information.

  pdf Media Release: PBS treatments